These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 34401208)

  • 21. Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions.
    Zheng Q; Yang Q; Zhou J; Gu X; Zhou H; Dong X; Zhu H; Chen Z
    Cancer Cell Int; 2021 Jun; 21(1):330. PubMed ID: 34193146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling.
    Yu J; Xie M; Ge S; Chai P; Zhou Y; Ruan J
    Front Oncol; 2020; 10():580029. PubMed ID: 33330057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
    Chen W; Tang D; Ou M; Dai Y
    DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
    Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
    Front Oncol; 2020; 10():541330. PubMed ID: 33072571
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel immunogenomic classification for prognosis in non-small cell lung cancer.
    Tang S; Xu L; Wu Z; Wen Q; Li H; Li N
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10951-10964. PubMed ID: 37329462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma.
    Li Y; He X; Zhang X; Xu Y; Wu Y; Xu X
    Life Sci; 2021 Jan; 265():118799. PubMed ID: 33220285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment.
    Du Y; Ma Y; Zhu Q; Liu T; Jiao Y; Yuan P; Wang X
    Front Pharmacol; 2021; 12():707930. PubMed ID: 34248650
    [No Abstract]   [Full Text] [Related]  

  • 29. CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates.
    Nie Y; Jiang MC; Liu C; Liu Q; Zhu X
    Front Oncol; 2021; 11():637023. PubMed ID: 33869023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma.
    Pan L; Fang J; Chen MY; Zhai ST; Zhang B; Jiang ZY; Juengpanich S; Wang YF; Cai XJ
    World J Gastroenterol; 2020 Feb; 26(8):789-803. PubMed ID: 32148377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.
    Hu B; Yang XB; Sang XT
    Int Immunopharmacol; 2021 Jan; 90():107164. PubMed ID: 33172741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated Multi-Omics Data Analysis Reveals Associations Between Glycosylation and Stemness in Hepatocellular Carcinoma.
    Liu P; Zhou Q; Li J
    Front Oncol; 2022; 12():913432. PubMed ID: 35814473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
    Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
    Front Oncol; 2020; 10():780. PubMed ID: 32587825
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular Carcinoma.
    Chen X; Wang L; Hong L; Su Z; Zhong X; Zhou H; Zhang X; Wu J; Shao L
    Front Genet; 2021; 12():661988. PubMed ID: 34262594
    [No Abstract]   [Full Text] [Related]  

  • 36. Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma.
    Xu L; Jian X; Liu Z; Zhao J; Zhang S; Lin Y; Xie L
    Front Genet; 2021; 12():741226. PubMed ID: 34646307
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients.
    Wang W; Zhang C; Yu Q; Zheng X; Yin C; Yan X; Liu G; Song Z
    BMC Gastroenterol; 2021 Feb; 21(1):68. PubMed ID: 33579192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined signature of nine immune-related genes: a novel risk score for predicting prognosis in hepatocellular carcinoma.
    Tang Y; Zeng Z; Wang J; Li G; Huang C; Dong X; Feng Z
    Am J Transl Res; 2020; 12(4):1184-1202. PubMed ID: 32355535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
    Gu X; Guan J; Xu J; Zheng Q; Chen C; Yang Q; Huang C; Wang G; Zhou H; Chen Z; Zhu H
    J Transl Med; 2021 Jan; 19(1):26. PubMed ID: 33407546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.